Using an electronic medical record patient portal for warfarin self-management: Empowering children and parents

Many children taking warfarin perform their international normalized ratio (INR) at home, with results phoned to a clinician who instructs warfarin dosing. Data suggest that parents can be supported to make warfarin dosing decisions themselves, a process known as patient self-management (PSM). This...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research and practice in thrombosis and haemostasis 2023-02, Vol.7 (2), p.100066-100066, Article 100066
Hauptverfasser: Jones, Sophie, Hislop, Jodi L., Gilmore, Hollie, Greenway, Anthea, Hibbard, James, Monagle, Paul, Newall, Fiona
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100066
container_issue 2
container_start_page 100066
container_title Research and practice in thrombosis and haemostasis
container_volume 7
creator Jones, Sophie
Hislop, Jodi L.
Gilmore, Hollie
Greenway, Anthea
Hibbard, James
Monagle, Paul
Newall, Fiona
description Many children taking warfarin perform their international normalized ratio (INR) at home, with results phoned to a clinician who instructs warfarin dosing. Data suggest that parents can be supported to make warfarin dosing decisions themselves, a process known as patient self-management (PSM). This study aimed to determine the suitability and acceptability of warfarin PSM in children using the Epic Patient Portal. Children currently performing INR patient self-testing were eligible. Participation involved an individualized education session, adherence to the PSM program, and participation in phone interviews. Clinical outcomes (INR time in therapeutic range and safety outcomes), patient portal functionality, and family experience were assessed. The hospital human research ethics committee approved the study and consent was obtained from parents/guardians. Twenty-four families undertook PSM. The median age of children was 11 years and all children had congenital heart disease. A median of 13 INRs was uploaded to the portal per family (range, 8-47) across a 10-month period. Before PSM, the mean time the INR was in therapeutic range was 71%; this increased to 79.9% during PSM (difference: P < .001). No adverse events were encountered. Eight families participated in a phone interview. The major theme identified was empowerment; minor themes that emerged included “gaining knowledge,” “trust and responsibility builds confidence,” “saving time,” and “resources as a safety net.” This study demonstrates that communication via the Epic Patient Portal is satisfactory to families and offers a suitable option for PSM for children. Importantly, PSM empowers and builds confidence in families to facilitate management of their child’s health. •Evidence suggests that families can be taught to dose-adjust to their child’s warfarin.•A patient self-management (PSM) program was established using a patient portal.•The mean time the international normalized ratio was in range during PSM was 79.9%.•PSM via the Epic Patient Portal empowered parents and streamlined communication.
doi_str_mv 10.1016/j.rpth.2023.100066
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9986642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2475037923000328</els_id><sourcerecordid>2785198643</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-af3b8378d740b051fe36ca2cc9d2fe3c78fc2a61bc38a0a598bf093fc13096803</originalsourceid><addsrcrecordid>eNp9kc1q3DAURkVpaUKSF-iiaNmNp_qxZbmUQglpWghk06yFfC3NaLAlV_Ik5O17zSQh3RQEukhH35V0CPnA2YYzrj7vN3ledhvBhMQFxpR6Q05F3TYVk2339lV9Qi5K2SOCLI7mPTmRSndctO0pSXclxC21kbrRwZJTDEAnNwSwI80OUh7obJfg4kLnlBdc9SnTB5u9zSHS4kZfTTbarZuQ-UKvpjk9uLyGwi6MQ3YR09cQrJZyTt55OxZ38TSfkbsfV78vf1Y3t9e_Lr_fVFA3zVJZL3stWz20NetZw72TCqwA6AaBNbTag7CK9yC1ZbbpdO9ZJz1wyTqlmTwj346586HH5wD2znY0cw6TzY8m2WD-3YlhZ7bp3nSdVqoWGPDpKSCnPwdXFjOFAm4cbXTpUIxodcORrSWi4ohCTqVk51_acGZWWWZvVllmlWWOsvDQx9cXfDnyrAaBr0fA4TfdB5dNAdQA6Aa9LGZI4X_5fwGGn6j5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2785198643</pqid></control><display><type>article</type><title>Using an electronic medical record patient portal for warfarin self-management: Empowering children and parents</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Jones, Sophie ; Hislop, Jodi L. ; Gilmore, Hollie ; Greenway, Anthea ; Hibbard, James ; Monagle, Paul ; Newall, Fiona</creator><creatorcontrib>Jones, Sophie ; Hislop, Jodi L. ; Gilmore, Hollie ; Greenway, Anthea ; Hibbard, James ; Monagle, Paul ; Newall, Fiona</creatorcontrib><description>Many children taking warfarin perform their international normalized ratio (INR) at home, with results phoned to a clinician who instructs warfarin dosing. Data suggest that parents can be supported to make warfarin dosing decisions themselves, a process known as patient self-management (PSM). This study aimed to determine the suitability and acceptability of warfarin PSM in children using the Epic Patient Portal. Children currently performing INR patient self-testing were eligible. Participation involved an individualized education session, adherence to the PSM program, and participation in phone interviews. Clinical outcomes (INR time in therapeutic range and safety outcomes), patient portal functionality, and family experience were assessed. The hospital human research ethics committee approved the study and consent was obtained from parents/guardians. Twenty-four families undertook PSM. The median age of children was 11 years and all children had congenital heart disease. A median of 13 INRs was uploaded to the portal per family (range, 8-47) across a 10-month period. Before PSM, the mean time the INR was in therapeutic range was 71%; this increased to 79.9% during PSM (difference: P &lt; .001). No adverse events were encountered. Eight families participated in a phone interview. The major theme identified was empowerment; minor themes that emerged included “gaining knowledge,” “trust and responsibility builds confidence,” “saving time,” and “resources as a safety net.” This study demonstrates that communication via the Epic Patient Portal is satisfactory to families and offers a suitable option for PSM for children. Importantly, PSM empowers and builds confidence in families to facilitate management of their child’s health. •Evidence suggests that families can be taught to dose-adjust to their child’s warfarin.•A patient self-management (PSM) program was established using a patient portal.•The mean time the international normalized ratio was in range during PSM was 79.9%.•PSM via the Epic Patient Portal empowered parents and streamlined communication.</description><identifier>ISSN: 2475-0379</identifier><identifier>EISSN: 2475-0379</identifier><identifier>DOI: 10.1016/j.rpth.2023.100066</identifier><identifier>PMID: 36891277</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>anticoagulants ; child ; electronic medical record ; Original ; patient portals ; self-management ; warfarin</subject><ispartof>Research and practice in thrombosis and haemostasis, 2023-02, Vol.7 (2), p.100066-100066, Article 100066</ispartof><rights>2023 The Author(s)</rights><rights>2023 The Author(s).</rights><rights>2023 The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-af3b8378d740b051fe36ca2cc9d2fe3c78fc2a61bc38a0a598bf093fc13096803</citedby><cites>FETCH-LOGICAL-c455t-af3b8378d740b051fe36ca2cc9d2fe3c78fc2a61bc38a0a598bf093fc13096803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986642/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986642/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36891277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jones, Sophie</creatorcontrib><creatorcontrib>Hislop, Jodi L.</creatorcontrib><creatorcontrib>Gilmore, Hollie</creatorcontrib><creatorcontrib>Greenway, Anthea</creatorcontrib><creatorcontrib>Hibbard, James</creatorcontrib><creatorcontrib>Monagle, Paul</creatorcontrib><creatorcontrib>Newall, Fiona</creatorcontrib><title>Using an electronic medical record patient portal for warfarin self-management: Empowering children and parents</title><title>Research and practice in thrombosis and haemostasis</title><addtitle>Res Pract Thromb Haemost</addtitle><description>Many children taking warfarin perform their international normalized ratio (INR) at home, with results phoned to a clinician who instructs warfarin dosing. Data suggest that parents can be supported to make warfarin dosing decisions themselves, a process known as patient self-management (PSM). This study aimed to determine the suitability and acceptability of warfarin PSM in children using the Epic Patient Portal. Children currently performing INR patient self-testing were eligible. Participation involved an individualized education session, adherence to the PSM program, and participation in phone interviews. Clinical outcomes (INR time in therapeutic range and safety outcomes), patient portal functionality, and family experience were assessed. The hospital human research ethics committee approved the study and consent was obtained from parents/guardians. Twenty-four families undertook PSM. The median age of children was 11 years and all children had congenital heart disease. A median of 13 INRs was uploaded to the portal per family (range, 8-47) across a 10-month period. Before PSM, the mean time the INR was in therapeutic range was 71%; this increased to 79.9% during PSM (difference: P &lt; .001). No adverse events were encountered. Eight families participated in a phone interview. The major theme identified was empowerment; minor themes that emerged included “gaining knowledge,” “trust and responsibility builds confidence,” “saving time,” and “resources as a safety net.” This study demonstrates that communication via the Epic Patient Portal is satisfactory to families and offers a suitable option for PSM for children. Importantly, PSM empowers and builds confidence in families to facilitate management of their child’s health. •Evidence suggests that families can be taught to dose-adjust to their child’s warfarin.•A patient self-management (PSM) program was established using a patient portal.•The mean time the international normalized ratio was in range during PSM was 79.9%.•PSM via the Epic Patient Portal empowered parents and streamlined communication.</description><subject>anticoagulants</subject><subject>child</subject><subject>electronic medical record</subject><subject>Original</subject><subject>patient portals</subject><subject>self-management</subject><subject>warfarin</subject><issn>2475-0379</issn><issn>2475-0379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kc1q3DAURkVpaUKSF-iiaNmNp_qxZbmUQglpWghk06yFfC3NaLAlV_Ik5O17zSQh3RQEukhH35V0CPnA2YYzrj7vN3ledhvBhMQFxpR6Q05F3TYVk2339lV9Qi5K2SOCLI7mPTmRSndctO0pSXclxC21kbrRwZJTDEAnNwSwI80OUh7obJfg4kLnlBdc9SnTB5u9zSHS4kZfTTbarZuQ-UKvpjk9uLyGwi6MQ3YR09cQrJZyTt55OxZ38TSfkbsfV78vf1Y3t9e_Lr_fVFA3zVJZL3stWz20NetZw72TCqwA6AaBNbTag7CK9yC1ZbbpdO9ZJz1wyTqlmTwj346586HH5wD2znY0cw6TzY8m2WD-3YlhZ7bp3nSdVqoWGPDpKSCnPwdXFjOFAm4cbXTpUIxodcORrSWi4ohCTqVk51_acGZWWWZvVllmlWWOsvDQx9cXfDnyrAaBr0fA4TfdB5dNAdQA6Aa9LGZI4X_5fwGGn6j5</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Jones, Sophie</creator><creator>Hislop, Jodi L.</creator><creator>Gilmore, Hollie</creator><creator>Greenway, Anthea</creator><creator>Hibbard, James</creator><creator>Monagle, Paul</creator><creator>Newall, Fiona</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230201</creationdate><title>Using an electronic medical record patient portal for warfarin self-management: Empowering children and parents</title><author>Jones, Sophie ; Hislop, Jodi L. ; Gilmore, Hollie ; Greenway, Anthea ; Hibbard, James ; Monagle, Paul ; Newall, Fiona</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-af3b8378d740b051fe36ca2cc9d2fe3c78fc2a61bc38a0a598bf093fc13096803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>anticoagulants</topic><topic>child</topic><topic>electronic medical record</topic><topic>Original</topic><topic>patient portals</topic><topic>self-management</topic><topic>warfarin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jones, Sophie</creatorcontrib><creatorcontrib>Hislop, Jodi L.</creatorcontrib><creatorcontrib>Gilmore, Hollie</creatorcontrib><creatorcontrib>Greenway, Anthea</creatorcontrib><creatorcontrib>Hibbard, James</creatorcontrib><creatorcontrib>Monagle, Paul</creatorcontrib><creatorcontrib>Newall, Fiona</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Research and practice in thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jones, Sophie</au><au>Hislop, Jodi L.</au><au>Gilmore, Hollie</au><au>Greenway, Anthea</au><au>Hibbard, James</au><au>Monagle, Paul</au><au>Newall, Fiona</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using an electronic medical record patient portal for warfarin self-management: Empowering children and parents</atitle><jtitle>Research and practice in thrombosis and haemostasis</jtitle><addtitle>Res Pract Thromb Haemost</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>7</volume><issue>2</issue><spage>100066</spage><epage>100066</epage><pages>100066-100066</pages><artnum>100066</artnum><issn>2475-0379</issn><eissn>2475-0379</eissn><abstract>Many children taking warfarin perform their international normalized ratio (INR) at home, with results phoned to a clinician who instructs warfarin dosing. Data suggest that parents can be supported to make warfarin dosing decisions themselves, a process known as patient self-management (PSM). This study aimed to determine the suitability and acceptability of warfarin PSM in children using the Epic Patient Portal. Children currently performing INR patient self-testing were eligible. Participation involved an individualized education session, adherence to the PSM program, and participation in phone interviews. Clinical outcomes (INR time in therapeutic range and safety outcomes), patient portal functionality, and family experience were assessed. The hospital human research ethics committee approved the study and consent was obtained from parents/guardians. Twenty-four families undertook PSM. The median age of children was 11 years and all children had congenital heart disease. A median of 13 INRs was uploaded to the portal per family (range, 8-47) across a 10-month period. Before PSM, the mean time the INR was in therapeutic range was 71%; this increased to 79.9% during PSM (difference: P &lt; .001). No adverse events were encountered. Eight families participated in a phone interview. The major theme identified was empowerment; minor themes that emerged included “gaining knowledge,” “trust and responsibility builds confidence,” “saving time,” and “resources as a safety net.” This study demonstrates that communication via the Epic Patient Portal is satisfactory to families and offers a suitable option for PSM for children. Importantly, PSM empowers and builds confidence in families to facilitate management of their child’s health. •Evidence suggests that families can be taught to dose-adjust to their child’s warfarin.•A patient self-management (PSM) program was established using a patient portal.•The mean time the international normalized ratio was in range during PSM was 79.9%.•PSM via the Epic Patient Portal empowered parents and streamlined communication.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36891277</pmid><doi>10.1016/j.rpth.2023.100066</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2475-0379
ispartof Research and practice in thrombosis and haemostasis, 2023-02, Vol.7 (2), p.100066-100066, Article 100066
issn 2475-0379
2475-0379
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9986642
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects anticoagulants
child
electronic medical record
Original
patient portals
self-management
warfarin
title Using an electronic medical record patient portal for warfarin self-management: Empowering children and parents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A16%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20an%20electronic%20medical%20record%20patient%20portal%20for%20warfarin%20self-management:%20Empowering%20children%20and%20parents&rft.jtitle=Research%20and%20practice%20in%20thrombosis%20and%20haemostasis&rft.au=Jones,%20Sophie&rft.date=2023-02-01&rft.volume=7&rft.issue=2&rft.spage=100066&rft.epage=100066&rft.pages=100066-100066&rft.artnum=100066&rft.issn=2475-0379&rft.eissn=2475-0379&rft_id=info:doi/10.1016/j.rpth.2023.100066&rft_dat=%3Cproquest_pubme%3E2785198643%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2785198643&rft_id=info:pmid/36891277&rft_els_id=S2475037923000328&rfr_iscdi=true